Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Thrombosis and Haemostasis|January 5, 2005
Elevated plasma osteoprotegerin levels are associated with venous thrombosis and bleeding in patients with polycythemia veraMathias Kees, Franz Wiesbauer, Bettina Gisslinger, et al.
The Journal of Clinical Investigation|March 3, 2004
TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemiaMedhat Shehata, Josef D Schwarzmeier, Martin Hilgarth, et al.
Blood|March 31, 2011
Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classificationJürgen Thiele, Hans Michael Kvasnicka, Leonhard Müllauer, et al.
Blood|January 16, 2008
Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutationsSai Li, Robert Kralovics, Gennaro De Libero, et al.
Leukemia Research|November 23, 2013
High spontaneous granulocyte/macrophage-colony formation in patients with myelofibrosisVerena Hauer, Eva Jäger, Thamer Sliwa, et al.
The New England Journal of Medicine|January 9, 2004
Efficacy and safety of low-dose aspirin in polycythemia veraRaffaele Landolfi, Roberto Marchioli, Jack Kutti, et al.
Cancer|October 12, 2004
Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profileMichael Steurer, Guenther Gastl, Wieslaw-Wiktor Jedrzejczak, et al.
Nature Genetics|March 17, 2009
A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasmsDamla Olcaydu, Ashot Harutyunyan, Roland Jäger, et al.
European Journal of Haematology|May 10, 2016
In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemiaKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Pageof 15